ALK c.668-25817A>G

Variant ID: 2-29966380-T-C

NM_004304.4(ALK):c.668-25817A>G

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs6754181
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.

Bmc Medical Genomics
Koestler, Devin C DC; Chalise, Prabhakar P; Cicek, Mine S MS; Cunningham, Julie M JM; Armasu, Sebastian S; Larson, Melissa C MC; Chien, Jeremy J; Block, Matthew M; Kalli, Kimberly R KR; Sellers, Thomas A TA; Fridley, Brooke L BL; Goode, Ellen L EL
Publication Date: 2014-01-30

Variant appearance in text: rs6754181
PubMed Link: 24479488
Variant Present in the following documents:
  • Main text
  • 1755-8794-7-8.pdf
View BVdb publication page